Joseph A. Ladapo, MD, PhD Profile picture
25th State Health Officer & Surgeon General of the great state of Florida. Father of three. Runner. Advocate for healthy living.
SaiTama Profile picture 1 subscribed
Oct 18, 2023 4 tweets 1 min read
Not exactly, @CDCDirector…
 
Multiple studies show negative vaccine effectiveness after a few months, meaning that people who receive the mRNA vaccines appear to have an increased risk of COVID infection. And the safety profile is terrible. jamanetwork.com/journals/jaman…
Jan 19, 2023 5 tweets 2 min read
@CDCgov says signals of stroke risk with mRNA vaccination shouldn’t be taken seriously since other countries haven’t “flagged this safety issue.” 🧵reuters.com/business/healt… But Scandinavian countries found this signal in population studies more than six months ago with the original mRNA COVID-19 vaccines! jamanetwork.com/journals/jaman…
Jan 10, 2023 4 tweets 2 min read
👏🏼Bravo to these Harvard-affiliated researchers for finding that spike protein persists in the blood of young people who develop myocarditis after receiving mRNA COVID-19 vaccines, which may explain the mechanism of injury... 🧵
ahajournals.org/doi/10.1161/CI… However, the same researchers at @MassGenBrigham felt the need to immediately back-pedal in a press release in order to defend these vaccines’ adverse effects. "Risk of severe COVID-19" is still higher, they say. Are you sure that's true for young people? newswise.com/coronavirus/re…
Oct 10, 2022 7 tweets 1 min read
I love the discussion that we've stimulated.

Isn't it great when we discuss science transparently instead of trying to cancel one another?

I'm going to respond to the more substantive critiques.🧵 #1. "Diagnosis codes for cardiac-related deaths are imperfect."

Yes! But that is true for every subgroup we examined. Only in young men was the risk extremely high, and it was also increased in older men.
Dec 17, 2021 4 tweets 2 min read
Today, I joined @GovRonDeSantis to announce a new preventative COVID-19 monoclonal antibody therapy from AstraZeneca that will be available for immunocompromised individuals & those who have adverse reactions to the vaccine. According to clinical trials, recipients of this new monoclonal antibody therapy saw a 77 percent reduced risk of developing COVID-19. We must provide protection options for all, & FL will continue to respond to COVID-19 with tangible, innovative solutions.
Nov 4, 2021 4 tweets 2 min read
COVID-19 vaccines are effective at reducing the risk of severe illness, hospitalization & death. There are also concerns about uncommon but underreported adverse events, some data quality, & suppression of politically unpopular perspectives.

bit.ly/3q2y2Ya Powerful testimony by patients & researchers, led by @SenRonJohnson.

rumble.com/vokrf7-sen.-jo…